AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.

The injections were precise, the neck bands are gone — yet the neck suddenly looks worse? Why this happens, how to avoid missing the loss of tissue support, and what to rely on when making clinical decisions. Mechanisms behind the effect, common mistakes, and clear guidelines for safe correction.

Are exosomes capable of revolutionizing cosmetology? Discover how these microscopic “couriers” deliver active substances to cells, stimulating regeneration, rejuvenation, and anti-inflammatory processes. What makes them so effective, and could they truly be the future of aesthetic medicine?

Hyaluronic acid is a component of every living organism. But one of the most successful scientific discoveries to restore youthfulness to the skin is the possibility of using hyaluronic acid for cosmetic purposes.

When performing botulinum therapy on mature-age female patients, it is necessary to take into account all pathogenetic mechanisms involved in the formation of the clinical picture of menopausal facial aging.

Sample informed consent form for the administration of Botox.

Article coming soon This page is under preparation and will be available soon.  

On the correction of a gummy smile, mimic wrinkles, and age-related changes in the lower third of the face and neck, as well as combined techniques for the use of botulinum toxin type A.

On the correction of mimic wrinkles and age-related changes in the upper third of the face (forehead, glabella, eyebrows, eyes, nose) using botulinum toxin type A.

Allergan Announces Results of Higher Dose BOTOX® Cosmetic (onabotulinumtoxin A) for the Treatment of Moderate to Severe Glabellar Lines.